Cutting Edge Developments in Hereditary Angioedema: Insights Into 2024 EAACI

HAE is associated with a substantial burden of disease that negatively impacts patient quality of life. The unpredictable nature of this disease and variability in disease course adds to the burden and the impacts of HAE. As the nuances of HAE are being discovered, more areas for targeted therapy are being developed. Join our expert panel for a live conversation on social media as they discuss treatment challenges, unmet needs of patients living with HAE, and latest advances in HAE.

Friday, May 24, 2024
12:30pm - 1:00pm EDT

Faculty
William R. Lumry, MD
Aleena Banerji, MD

Supported by an independent educational grant from KalVista Pharmaceuticals and Ionis Pharmaceuticals. Review the disclosures: bit.ly/3WLH2Bk.

Видео Cutting Edge Developments in Hereditary Angioedema: Insights Into 2024 EAACI канала Medscape